The brain's master circadian clock: implications and opportunities for therapy of sleep disorders

Sleep Med Rev. 2007 Feb;11(1):59-70. doi: 10.1016/j.smrv.2006.06.001. Epub 2006 Sep 14.

Abstract

The suprachiasmatic nuclei (SCN) residing in the anterior hypothalamus maintains a near-24-h rhythm of electrical activity, even in the absence of environmental cues. This circadian rhythm is generated by intrinsic molecular mechanisms in the neurons of the SCN; however, the circadian clock is modulated by a wide variety of influences, including glutamate and pituitary adenylate cyclase-activating peptide (PACAP) from the retinohypothalamic tract, melatonin from the pineal gland, and neuropeptide Y from the intergeniculate leaflet. By virtue of these and other inputs, the SCN responds to environmental cues such as light, social and physical activities. In turn, the SCN controls or influences a wide variety of physiologic and behavioral functions, including attention, endocrine cycles, body temperature, melatonin secretion, and the sleep-wake cycle. Regulation of the sleep-wake cycle by the SCN has important implications for development of therapies for sleep disorders, including those involving desynchronization of circadian rhythms and insomnia.

Publication types

  • Review

MeSH terms

  • Antioxidants / therapeutic use
  • Body Temperature
  • Circadian Rhythm / physiology*
  • Humans
  • Hypothalamus / physiology*
  • Melatonin / physiology
  • Melatonin / therapeutic use
  • Phototherapy / methods*
  • Pituitary Adenylate Cyclase-Activating Polypeptide / physiology
  • Retinal Ganglion Cells / physiology
  • Sleep Disorders, Circadian Rhythm / physiopathology
  • Sleep Wake Disorders / drug therapy
  • Sleep Wake Disorders / therapy*
  • Wakefulness / physiology

Substances

  • Antioxidants
  • Pituitary Adenylate Cyclase-Activating Polypeptide
  • Melatonin